Clinical Trials Logo

Filter by:
NCT ID: NCT00801450 Active, not recruiting - Clinical trials for Diabetic Macular Edema

Intravitreal Injection Versus Sub-Tenon's Infusion of Triamcinolone Acetonide for Refractory Diabetic Macular Edema During Cataract Surgery

Start date: September 2007
Phase: Phase 1/Phase 2
Study type: Interventional

Triamcinolone has already been used by different routes of administration to treat diabetic macular edema. In the present study, intravitreal injection (IVI) and posterior sub-Tenon's infusion (STI) of triamcinolone acetonide (TA) during phacoemulsification cataract surgery in eyes with refractory diffuse diabetic macular edema are tested.

NCT ID: NCT00801359 Completed - Cataract Clinical Trials

BSSPlus Versus Lactated Ringer's for Phacoemulsification

Start date: January 2008
Phase: Phase 2
Study type: Interventional

Two intraocular irrigating solutions (BSSPlus versus Lactated Ringer's) are compared in this prospective, randomized, masked trial to investigate for differences in preservation of corneal integrity after phacoemulsification cataract surgery.

NCT ID: NCT00800774 Completed - Anisometropia Clinical Trials

Ten-year Follow-up of Laser in Situ Keratomileusis in Patients 8 to 15 Years Old

Start date: January 1998
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine the safety, efficacy, predictability, and stability of laser in situ keratomileusis (LASIK) to correct high anisometropia in patients 8 to 15 years old in whom conventional treatments have failed.

NCT ID: NCT00800657 Recruiting - Heart Failure Clinical Trials

Stem Cells and Resynchronization Cardiac

RCT and SCT
Start date: November 2008
Phase: Phase 1
Study type: Interventional

Same patients with dilated myocardiopathies with large areas of fibrosis has not been as successful after Cardiac Resynchronization Therapy, for Heart Failure patients in functional class III or IV. Therefore the investigators have decided to associate the Stem-Cell implant with Cardiac Resynchronization Therapy in these patients.

NCT ID: NCT00800176 Completed - Clinical trials for Diabetes Mellitus Type 2

A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus

Start date: January 22, 2009
Phase: Phase 2
Study type: Interventional

This 6 arm study will evaluate the efficacy, safety and pharmacokinetics of 5 doses of RO4998452 compared to placebo in patients with type 2 diabetes mellitus. Patients will be randomized to one of 6 groups to receive RO4998452 at doses of 2.5mg, 5mg, 10mg, 20mg or 40mg po daily, or placebo daily. Patients pre-treated with stable metformin will continue to take their usual dose of metformin throughout the study.The anticipated time on study treatment is <=3 months

NCT ID: NCT00800137 Terminated - Hematoma Clinical Trials

Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial

BRUISECONTROL
Start date: December 2008
Phase: Phase 4
Study type: Interventional

Many cardiac patients requiring device (defibrillator or pacemaker) related surgery are on chronic oral anticoagulation therapy (usually coumadin). The risk of blood clot formation related to stopping oral anti-coagulant therapy is currently managed by using bridging heparin therapy in patients with moderate to high risk of blood clot formation. There is a substantial risk of bleeding in the pocket where the device is situated (pocket hematoma)related to bridging therapy. The purpose of this study is to compare the current standard of care of bridging with heparin to an experimental strategy of continuing coumadin therapy in higher risk patients undergoing device surgery, with the hypothesis being that the continued oral anti-coagulation group will have a lower pocket hematoma rate as compared to the bridging with heparin group.

NCT ID: NCT00799903 Completed - Atherosclerosis Clinical Trials

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

STABILITY
Start date: December 2008
Phase: Phase 3
Study type: Interventional

This study will test whether darapladib can safely lower the chances of having a cardiovascular event (such as a heart attack or stroke) in people with coronary heart disease.

NCT ID: NCT00799851 Completed - Liver Disease Clinical Trials

A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal Varices

Start date: November 2004
Phase: Phase 4
Study type: Interventional

Compare VBL and cyanoacrylate injection (CI) in the treatment of EV in patients with advanced liver disease regarding eradication, bleeding, mortality, complication and recurrence rates.

NCT ID: NCT00799838 Terminated - Pharyngotonsillitis Clinical Trials

Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients

DROPS
Start date: November 2008
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the inflammatory symptoms and signs (hyperemia, edema and pain) reduction after 24 hours of treatment with ketoprofen drops when associated to amoxicillin.

NCT ID: NCT00799162 Recruiting - Postoperative Pain Clinical Trials

Prediction of Post-Cesarean Section Pain

PPCSP
Start date: November 2008
Phase: N/A
Study type: Observational

The purpose of this study is to determine if dynamic psychophysical testing along with genetic screening will allow to identify pre-operatively women who will suffer severe acute pain post-operatively and the subset who may experience chronic pain following cesarean section.